drugset / Trial / NCT06863363
PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults
RandomizedParallel-groupOpen-labelTreatment
Summary
This study aims to evaluate the efficacy and safety of PEG-rhGH Injection combined with Semaglutide Injection versus Semaglutide Injection monotherapy in improving body composition (lean body mass, fat mass, etc.) in non-diabetic obese adults, while also analyzing changes in body weight, blood glucose, and other metabolic parameters.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PEG-rhGH | Protein / enzyme biologic | 2 mg | Subcutaneous |
| Comparator | Semaglutide | Peptide | 2.4 mg | Subcutaneous |